Sandoz

Founded as Kern & Sandoz in 1886, the company now known as Sandoz is headquartered in Holzkirchen, Germany, and has established itself as a key player in the pharmaceutical industry. Specializing in generic drugs, biosimilars, pharmaceutical, and biotechnological active substances, Sandoz has a diversely ranged portfolio. Among the most well-known offerings are products such as Omnitrope, which is a biosimilar of somatropin, Zarxio, a biosimilar of filgrastim, and Erelzi, which stands as a biosimilar of etanercept. With a global presence, Sandoz has marked its importance in markets like the United States and Europe, addressing the demand for high-quality, affordable generics and biosimilars across these regions and other countries around the world. (Powered by AI)